Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. - Test2 - elhamkhani - TriplyDB

Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.

Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.

http://www.wikidata.org/entity/Q35076119

about

Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset Self-reported sleep and β-amyloid deposition in community-dwelling older adults.The future of blood-based biomarkers for Alzheimer's disease.Plasma based markers of [11C] PiB-PET brain amyloid burden.Plasma proteins predict conversion to dementia from prodromal disease Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation.Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype Blood protein predictors of brain amyloid for enrichment in clinical trials?Alzheimer's disease: are blood and brain markers related? A systematic review.Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.Brain asymmetry: both sides of the story.The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.Personalized protein corona on nanoparticles and its clinical implications.Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load.Effect of apolipoprotein E phenotype on the association of plasma amyloid β and amyloid positron emission tomography imaging in Japan.Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2 Apolipoproteins and Alzheimer's pathophysiology

P2860

Q26774743-D3A1E78F-F408-4B54-8EB3-8E67E6EBB249 Q28730795-7EB6B8D5-BC97-4B7A-823D-33D0C97C8F4A Q30571257-47AFF82A-B5EC-4FE3-B8EF-7E4A98EEB366 Q34026317-8E231ED6-65B4-40B2-B04A-B49FA7771004 Q34427001-9EE266A3-FA73-4540-8BA7-5E0A6A80C4FF Q34556953-732D6928-8432-4DB1-AE6E-32F2169082E5 Q35071184-0531DC82-D8F0-4241-B7EE-02B131DDC255 Q35813149-80B6E824-45D5-49E9-B1EE-468F10D731F4 Q36165011-712C020E-3EE6-48E9-9871-12EA5C6E081A Q36430448-68D20A43-3D75-4F70-8CE2-486A666F2FE8 Q36503998-0FE37386-62DC-4610-8D3A-167F7B235E90 Q36926754-2254845F-7212-4520-9227-EAA280B122AA Q36966044-57080931-6FDF-4AA5-B52A-AB7EF09F74C2 Q37044150-7E87CED2-E0AB-4058-85AE-50B92D932EC2 Q37375828-E72A3EF5-1DB6-44EC-8501-7ABFCC292648 Q37956662-6ACE265E-A482-4880-B9A8-AA034550E25C Q37978548-08F4DB4B-480C-4624-9501-4741BAD0A49B Q39108612-10323026-9CC1-4568-AC6D-B4AA41FC4189 Q40139851-090CCB9A-BE46-4CC5-B15D-CACEEADD5D67 Q42026115-F26C7996-30B2-494E-9C8C-4E4E6D72CF32 Q43244936-AB2FFC31-4BDF-4A98-B898-21B2FB1BB78B Q47407570-DE8772DD-56C0-4A9A-9051-6DFD8FF85BC6 Q47417067-A6A028E6-9FE8-4FEE-8A1A-0D1A9220289B Q50221800-00B5F0D9-4A22-4C10-BB73-97D215251975 Q51760901-634D38BB-604D-4A5A-AF7D-2C92F072BF8D Q52609763-EFD61E21-823C-45E3-A435-7F4896337E5C Q57153825-098FAF64-B7E1-4780-A1B1-83B4F58AACD1 Q57268327-659EFC86-E4AE-414A-9F23-9C3E107B53A7 Q58129974-D577EECB-24E1-4EE6-9145-EC1B4690B6F7

P2860

Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.

http://www.wikidata.org/entity/Q35076119

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Proteome-based plasma markers ...... on-demented older individuals.

@ast

Proteome-based plasma markers ...... on-demented older individuals.

@en

type

label

Proteome-based plasma markers ...... on-demented older individuals.

@ast

Proteome-based plasma markers ...... on-demented older individuals.

@en

prefLabel

Proteome-based plasma markers ...... on-demented older individuals.

@ast

Proteome-based plasma markers ...... on-demented older individuals.

@en

P1433

Q35076119-3677209C-8C22-4895-BBAF-E85EABD79357

P1476

Q35076119-2764D0E0-139A-4688-966B-D85A4345B412

P2093

Q35076119-07AD8C12-720C-4AB3-8552-2F9D4C43CD6C

Q35076119-4A2F2D45-68ED-4E2B-96CC-BAF73D7E1BCE

Q35076119-5D69FDB5-33BD-4F17-8B44-20AC8137F2C5

Q35076119-6EA5B034-B9D9-433B-83B7-421E0B17D15E

Q35076119-6FB1BC6C-E4FF-4D87-9A79-8EFB4492D25C

Q35076119-7A2D1D57-0580-4163-BB8B-398EBF5B0957

Q35076119-AAD9641E-88CA-4FD3-9FFF-A08AF6624517

Q35076119-FF75C885-4411-4053-AE33-75F244BB5CCA

P2860

Q35076119-04F430FD-5E97-4DA0-8457-DF04956E5122

Q35076119-09D25F91-4B36-40D2-8CE4-8D99796019D9

Q35076119-0A4BFC16-0680-4380-8D03-55143F2E6911

Q35076119-14EE52BE-78B9-4F93-9FE3-8CF460F4EAA3

Q35076119-184DAB56-DE46-425F-B81F-442FE30E5302

Q35076119-1A372729-E390-4419-B1B1-9B6559636BD6

Q35076119-222E94C2-9436-4188-8CDF-7341741A1C16

Q35076119-2652E734-1571-484E-9B27-75613732A5A2

Q35076119-2942F3B8-4416-401C-AA25-1D6155E900E4

Q35076119-2CA24658-6CCE-4DC9-A0B1-A653892C0772

P304

Q35076119-9F7C363E-6AFD-4F59-BCF6-3BD63EF1BE8B

P31

Q35076119-639C3492-1A61-4544-8DF5-8ADEBF93E383

P356

Q35076119-432A2FA5-5E01-47C7-8A2D-A7B3AF374A1F

P433

Q35076119-03E1F537-534F-4541-96C8-A6B84C6DDB2D

P478

Q35076119-AE7896C5-DCDB-44CC-B611-09E42DE7AA6F

P50

Q35076119-097A698C-7DF5-4564-9A34-CA37383DDFDD

Q35076119-0E37B265-F481-409A-AFF2-26F2DDFCA55C

Q35076119-239EEDE5-CA9D-4759-B07A-C83EA3F86F79

Q35076119-2BD46640-C7A2-4115-B77B-9F153EC083DC

Q35076119-7764B6CF-7E47-47FA-AAA4-3E7267554F5C

Q35076119-F6CA8E53-1E32-490B-933B-86DCF1B48010

P577

Q35076119-CC04FF3E-E2A0-48DE-BEA4-5E649EC0EFE1

P5875

Q35076119-BFF07B71-A3EB-4947-82AE-01173EC1FF0B

P698

Q35076119-4EED4660-7C45-4E1B-B371-8FA867EA2E7A

P932

Q35076119-AAC9D917-8E9D-47C4-91F4-E12023A034A1

P356

JAD-2010-101350

P1433

Journal of Alzheimer's Disease

P1476

Proteome-based plasma markers ...... on-demented older individuals.

@en

P2093

Abdul Hye

http://www.w3.org/2001/XMLSchema#string

Dean F Wong

http://www.w3.org/2001/XMLSchema#string

Jitka Sojkova

http://www.w3.org/2001/XMLSchema#string

Joanna Riddoch-Contreras

http://www.w3.org/2001/XMLSchema#string

Romina Tripaldi

http://www.w3.org/2001/XMLSchema#string

Susan M Resnick

http://www.w3.org/2001/XMLSchema#string

Yang An

http://www.w3.org/2001/XMLSchema#string

Yun Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Beta-amyloid deposition and the aging brain

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

Blood-based biomarkers of microvascular pathology in Alzheimer's disease.

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

Extracellular chaperones modulate the effects of Alzheimer's patient cerebrospinal fluid on Abeta(1-42) toxicity and uptake

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Proteome-based plasma biomarkers for Alzheimer's disease.

P304

1099-1109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2010-101350

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Simon Lovestone

Madhav Thambisetty

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47370369

http://www.w3.org/2001/XMLSchema#string

P698

20930274

http://www.w3.org/2001/XMLSchema#string

P932

3125970

http://www.w3.org/2001/XMLSchema#string